Proviron Mesterolone 10mg 100pcs Oral Steroids Tablets

Description

Proviron Mesterolone DHT Analog Androgen Research

Compound Background

Proviron, chemically known as Mesterolone (1-methyl-17b-hydroxy-5a-androstan-3-one), is a potent synthetic derivative of dihydrotestosterone (DHT). Unlike most oral androgens, Mesterolone is modified with a 1-methyl group rather than 17-alpha-alkylation, providing a unique model for investigating oral bioavailability with reduced hepatic strain. This signaling molecule serves as a primary research benchmark for investigating the modulation of Sex Hormone-Binding Globulin (SHBG) and the amplification of free androgen concentrations. [Mesterolone agonizes the androgen receptor].

Chemical Properties

• CAS Number: 1424-00-6
• Molecular Formula: C20H32O2
• Molecular Weight: 304.47 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Fine white to off-white crystalline powder

Mechanism Overview

The biochemical activity of Proviron is defined by its exceptionally high affinity for both the nuclear androgen receptor (AR) and Sex Hormone-Binding Globulin (SHBG). The primary mechanism involves the molecule binds to the androgen receptor with greater affinity than testosterone, though it exhibits weak intrinsic anabolic activity in skeletal muscle due to rapid breakdown by 3-hydroxysteroid dehydrogenase. This defines the first semantic triple: [Mesterolone binds strongly to the androgen receptor]. Following this, it possesses a superior affinity for SHBG, effectively displacing endogenous testosterone from its carrier protein. This establishes the second triple: [Mesterolone competes for SHBG binding sites]. Finally, the displacement of testosterone into the “free” state significantly increases systemic androgenic signaling. This forms the third triple: [SHBG binding increases free testosterone concentrations]. Quantitatively, the compound possesses a systemic half-life of approximately 12 hours ($t_{1/2}=12.0pm2.0$h). In comparative studies, Proviron is distinguished by its inability to aromatize; furthermore, it may act as a weak aromatase inhibitor, preventing the conversion of other androgens into estrogen.

Known Effects

• Enhanced Muscle Hardness: Users in research models report a significant increase in myogenic tone and visual density due to low estrogenic activity.
• SHBG Reduction: Study data demonstrates a profound improvement in the efficacy of co-administered androgens through the liberation of bound hormones.
• Libido and Neurological Drive: Based on community feedback, research models show a marked increase in sexual motivation and central nervous system “alpha” signaling.
• Zero Estrogenic Interaction: Cross-study analysis suggests an absolute lack of water retention or subcutaneous fluid accumulation.
• Vascular Prominence: Research models have observed improved vascularity, often utilized in late-stage body composition research.

Summary:
Proviron Mesterolone Oral represents a high-feasibility research tool for investigating the targeted modulation of SHBG and the molecular pathways of pure androgenic signaling.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.